Characterization of covalent Adriamycin-DNA adducts

Por Zeman, Steven M., Phillips, Don R., Crothers, Donald M.
Publicado em 1998

Formaldehyde activation of mitoxantrone yields CpG and CpA specific DNA adducts

Por Parker, Belinda S., Cutts, Suzanne M., Cullinane, Carleen, Phillips, Don R.
Publicado em 2000

Interstrand cross-linking by Adriamycin in nuclear and mitochondrial DNA of MCF-7 cells

Por Cullinane, Carleen, Cutts, Suzanne M., Panousis, Con, Phillips, Don R.
Publicado em 2000

Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent

Por Evison, Ben J., Mansour, Oula C., Menta, Ernesto, Phillips, Don R., Cutts, Suzanne M.
Publicado em 2007

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations

Por Coldwell, Kate E., Cutts, Suzanne M., Ognibene, Ted J., Henderson, Paul T., Phillips, Don R.
Publicado em 2008

Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: app...

Por Masarudin, Mas Jaffri, Cutts, Suzanne M, Evison, Benny J, Phillips, Don R, Pigram, Paul J
Publicado no Nanotechnol Sci Appl (2015)

Disparate Impact of Butyroyloxymethyl Diethylphosphate (AN-7), a Histone Deacetylase Inhibitor, and Doxorubicin in Mice Bearing a Mammary Tumor

Por Tarasenko, Nataly, Cutts, Suzanne M., Phillips, Don R., Inbal, Aida, Nudelman, Abraham, Kessler-Icekson, Gania, Rephaeli, Ada
Publicado em 2012

CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity

Por Evison, Benny J., Bilardi, Rebecca A., Chiu, Francis C. K., Pezzoni, Gabriella, Phillips, Don R., Cutts, Suzanne M.
Publicado em 2009